Skip to content

Acupuncture for Migraine Prophylaxis

A Continuous Study on Abiding Effect of Acupuncture for Migraine Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01687660
Acronym
AMP
Enrollment
249
Registered
2012-09-19
Start date
2012-09-30
Completion date
2014-09-30
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine Without Aura, Unilateral Headache

Keywords

acupuncture, migraine prophylaxis

Brief summary

Hypothesis: Acupuncture obtains an abiding effect on migraine prophylaxis Design: A open-label randomized controlled trial. 249 participants will be included. Three arms: acupuncture in acupoint-meridian, non-acupoint-meridian group, and waiting list.

Detailed description

Aim: to attest the abiding efficacy and safety of acupuncture for migraine prophylaxis Design: A open-label randomized controlled trial will be performed in Chengdu, Hunan and Chongqing province. Two hundred and forty-three participants will be randomly assign to acupoint-meridian group, non-acupoint-meridian group, and wait-and-see group. Each participants will receive 20 sessions of acupuncture in 4 weeks, with a duration of 30 minutes in a session. After all the treatments was accomplished, there will be 5 times follow-ups in the impending every 4 weeks. The primary outcome is frequency of migraine attacks 16 weeks after inclusion. Secondary outcomes include frequency of migraine attacks at the 4th and 24th week, headache severity, MSQ(Migraine Specific Quality of Life Questionnaire MSQ Version2.1), etc.

Interventions

OTHERacupuncture

apply acupuncture to prevent the migraine attack

Sponsors

Hunan University of Traditional Chinese Medicine
CollaboratorOTHER
Chongqing Medical University
CollaboratorOTHER
Li ying
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Age of a subject is between 18 and 65 years old(initially occured beneath the age of 50), male or female; * in accordance with diagnosis of migraine without aura in International Classification of Headache Disorders, ICHD-2, by IHS; * 2 to 8 times attack per month in recent 3 months, with each period beyond 15 days; * with migraine history for over 1 year; * be able and willing to finish the headache diary in baseline ; * informed consent form must be signed by patient or lineal relative;

Exclusion criteria

: * Patients who are unconscious, psychotic. * Patients with aggravating tumor and other serious consumptive disease, and who are subject to infection and bleeding. * With serious primary illness or disease of cardiovascular, liver, renal, gastrointestinal, hematological systems and so on. * Pregnant women or women in lactation.

Design outcomes

Primary

MeasureTime frameDescription
frequency of migraine attacks16th week after inclusionto assess the frequency of migraine attacks at the 16th week after inclusion

Secondary

MeasureTime frameDescription
frequency of migraine attacks4th and 24th week after inclusionto assess the frequency of migraine attacks at the 4th and 24th week respectively
headache severity0 day, 4th, 8th, 12th, 16th, 20th, 24th week after inclusionto evaluate the change of severity of headache

Other

MeasureTime frameDescription
MSQ(Migraine Specific Quality of Life Questionnaire MSQ Version2.1)the day of inclusion and 4th week after inclusionto observe the change of MSQ
acupuncture expectation scale1 dayan outcome to indicate the expectation of patient towards acupuncture treatment for migraine

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 22, 2026